1-3 of 3
Charlene Barroga, PhD
Close
Sort by
Journal Articles

A Novel Mouse Xenograft Model for Generation of JAK2 V617F Driven Leukemic Stem Cells From Human Embryonic Stem Cells.

Edward Kavalerchik, MD, Charlene Barroga, PhD, Larissa Balaian, PhD, Jennifer M. Black, MD, Catriona H.M. Jamieson, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 1433.
https://doi.org/10.1182/blood.V114.22.1433.1433
Published: 2009
Journal Articles

Selective Inhibition of JAK2 Driven Erythroid Differentiation of Polycythemia Vera Progenitors

Ifat Geron, MS, Annelie Abrahamsson, MS, Charlene Barroga, PhD, Edward Kavelerchik, MD, Jason R. Gotlib, MD MS, John D. Hood, PhD, Jeffrey Durocher, PhD, Chi Ching Mak, PhD, Glen Noronha, PhD, Richard Soll, PhD, Ayalew Tefferi, MD, Kenneth Kaushansky, MD, Catriona H.M. Jamieson, MD PhD
Journal: Blood
Blood (2007) 110 (11): 1526.
https://doi.org/10.1182/blood.V110.11.1526.1526
Published: 2007
Journal Articles

Inhibition of JAK2 V617F-Induced Erythroid Skewing of Hematopoietic Stem Cell Differentiation with a Selective JAK2 Antagonist.

Ifat Geron, MS, Charlene Barroga, PhD, Jason Gotlib, MD MS, Edward Kavalerchik, MD, Annelie Abrahamsson, MS, Daniel Goff, BS, Nicholas Cacalano, PhD, John Hood, PhD, Richard Soll, MD, Glenn Noronha, PhD, Ayalew Tefferi, MD, Irving L. Weissman, MD, Kenneth Kaushansky, MD PhD, Catriona Jamieson, MD, PhD
Journal: Blood
Blood (2006) 108 (11): 3616.
https://doi.org/10.1182/blood.V108.11.3616.3616
Published: 2006